We are live on
!
Find out more
AL
Aspiriant LLC Portfolio holdings
AUM
$3.51B
1-Year Est. Return
13.98%
This Fund
S&P 500
This Quarter
Est. Return
+3.34%
1 Year Est. Return
+13.98%
3 Year Est. Return
+39.43%
5 Year Est. Return
+43.32%
10 Year Est. Return
+133.07%
AUM
$341M
AUM Growth
-$852M
(-71%)
Cap. Flow
-$875M
Cap. Flow
% of AUM
-256.9%
Top 10 Holdings %
Top 10 Hldgs %
61.35%
Holding
204
New
1
Increased
1
Reduced
75
Closed
122
Top Buys
| 1 |
AMU
ETRACS Alerian MLP Index ETN
AMU
|
+$562K |
| 2 |
PRCP
Perceptron Inc
PRCP
|
+$91.4K |
Top Sells
| 1 |
iShares MSCI Global Min Vol Factor ETF
ACWV
|
+$76.3M |
| 2 |
MLPI
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
|
+$63.1M |
| 3 |
iShares Core S&P US Value ETF
IUSV
|
+$47.3M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$33.2M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$32.9M |
Sector Composition
| 1 | Financials | 6.67% |
| 2 | Communication Services | 2.66% |
| 3 | Healthcare | 1.09% |
| 4 | Technology | 0.9% |
| 5 | Consumer Discretionary | 0.65% |
Similar funds
BCP
ACA
IIM
TH
TYCC
TCM
DILIC
KCM
Aspiriant LLC's Q4 2017 Portfolio in Review
As of Q4 2017, Aspiriant LLC held 204 positions worth $341M, down 71% from $1.19B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Aspiriant LLC withdrew a net $875M in Q4 2017, closing 122 positions and reducing 75 holdings. Its most notable exit was iShares US Real Estate ETF, an estimated $32.9M position sold in full.
By sector, the portfolio is most concentrated in Financials at 6.7% of assets, up from 4.8% a quarter earlier, followed by Communication Services and Healthcare.
Against the trend, Aspiriant LLC opened a new position in Perceptron Inc worth $99K.
- Aspiriant LLC's largest Q4 2017 buy was Perceptron Inc: 10,143 shares worth $99K.
- Aspiriant LLC added most to ETRACS Alerian MLP Index ETN in Q4 2017, an estimated $562K increase.
- Aspiriant LLC's biggest Q4 2017 reduction was iShares MSCI Global Min Vol Factor ETF, cutting an estimated $76.3M.
- Aspiriant LLC fully exited iShares US Real Estate ETF in Q4 2017, selling an estimated $32.9M.
- Aspiriant LLC's ten largest holdings make up 61% of its $341M portfolio in Q4 2017.
- Aspiriant LLC opened 1 new position and closed 122 in Q4 2017.
- Aspiriant LLC's portfolio value fell 71% quarter-over-quarter to $341M.
Based on Aspiriant LLC's 13F filing for Q4 2017, filed 31 Jan 2018.